Emily Figueiredo Neves Yuki

Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial

Ana Cristina de Medeiros Ribeiro, Nádia Emi Aikawa, Carla Gonçalves Schahin Saad et al. · Nature Medicine · 2021 · 214 citations

Vaccination, Rheumatology, Vaccine Safety +10

Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial

Carlo Scognamiglio Renner Araújo, Ana Cristina de Medeiros Ribeiro, Carla Gonçalves Schahin Saad et al. · Annals of the Rheumatic Diseases · 2022 · 65 citations · Full text

Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases

Nádia Emi Aikawa, Léonard de Vinci Kanda Kupa, Ana Cristina de Medeiros Ribeiro et al. · Annals of the Rheumatic Diseases · 2022 · 49 citations

Impact of Distinct Therapies on Antibody Response to <scp>SARS‐CoV</scp>‐2 Vaccine in Systemic Lupus Erythematosus

Emily Figueiredo Neves Yuki, Eduardo Ferreira Borba, Sandra Gofinet Pasoto et al. · Arthritis Care & Research · 2021 · 41 citations · Full text

Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study

Nádia Emi Aikawa, Léonard de Vinci Kanda Kupa, Sandra Gofinet Pasoto et al. · The Lancet Rheumatology · 2021 · 32 citations · Full text